IN THE HIGH COURT OF KARNATAKA AT BENGALURU
M. NAGAPRASANNA, J.
Sri Sushil Goel, S/o Sri Shyamlal Goel – Appellant
Versus
State At The Instance Of Drugs Inspector -1 – Respondent
Criminal Petition No.6875 of 2020
Decided on : 10-05-2022
Drugs and Cosmetics Act - Vicarious Liability - Sections 18(a)(i), 22(i)(cca), 27(a), 22(3) - Summary of Acts and Sections: The court discussed the interpretation of Section 34 of the Drugs and Cosmetics Act, which deals with offences committed by a company. The judgment highlighted the requirement for specific attribution of roles to directors or partners of the company in the manufacturing process to establish vicarious liability. The court emphasized the need for clear and specific averments in the complaint regarding the role and responsibilities of the accused in the commission of the offence. The judgment also emphasized that vague statements about the accused being partners or directors of the company are insufficient to establish their involvement in the offences. The court quashed the proceedings against the petitioners as the complaint did not sufficiently establish their active role in the preparation and manufacture of drugs of sub-standard quality.
Fact of the Case:
The petitioners were accused of violating Sections 18(a)(i) and 22(i)(cca) of the Drugs and Cosmetics Act, 1940, for alleged offences punishable under Section 27(a) and 22(3). The complaint alleged that the petitioners, as directors and partners of a company, were responsible for manufacturing and selling drugs not of standard quality, leading to grievous harm to patients.
Finding of the Court:
The court found that the complaint did not sufficiently establish the active role of the petitioners in the preparation and manufacture of drugs of sub-standard quality. It emphasized the need for specific and clear averments regarding the role and responsibilities of the accused in the commission of the offence to establish vicarious liability.
Issues: The key issue was whether the complaint sufficiently attributed specific roles to the petitioners as directors and partners of the company in the manufacturing process to establish their vicarious liability for the alleged offences.
Ratio Decidendi: The court held that vague statements about the accused being partners or directors of the company are insufficient to establish their involvement in the offences. It emphasized the need for clear and specific averments in the complaint regarding the role and responsibilities of the accused in the commission of the offence to establish vicarious liability.
Final Decision: The court quashed the proceedings against the petitioners as the complaint did not sufficiently establish their active role in the preparation and manufacture of drugs of sub-standard quality.
ORDER :
Petitioners are before this Court calling in question proceedings in Special C.C.No.154 of 2020 pending before the Principal City Civil and Sessions Judge at Bangalore arising out of complaint filed under Section 200 of the Cr.P.C. for violation of Sections 18(a)(i) and 22(i)(cca) punishable under Section 27(a) and 22(3) of the Drugs and Cosmetics Act, 1940 (‘the Act’ for short).
2. Heard Sri. Desu Reddy G., learned Counsel for petitioners and Smt. K.P.Yashodha, learned High Court Government Pleader for respondent.
3. Brief facts leading to the filing of the present petition, as borne out from the pleadings, are as follows:-
It appears that on 12-07-2020 information was received by the Assistant Drugs Controller from the Superintendent of Minto Hospital, Bengaluru alleging that cataract surgeries had been carried out at the Hospital on 9-07-2019 and the patients who underwent cataract surgeries had developed eye infection. The said information was taken by the Assistant Drugs Controller and visited the hospital to investigate the matter. One Dr. K.M. Dakshayini hands over a letter to the respondent mentioning names of drugs which were used during cataract surgeries and also informed that consumables and drugs that were used in the cataract surgeries were sent to gram stain, culture sensitivity to microbiology laboratory and culture sensitivity report was given by the Department of microbiology, Victoria Hospital on 12.07.2019 which yielded pseudomonas aueroginosa growth in drug Hydroxypropyl Methylcellulose Ophthalmic Solution USP (OCCUGEL 2%) Batch No.OUV190203 date of Mfg.Feb.2019 Date of Exp. Jan.2021 manufactured by M/s Ophtechnics Unlimited.
4. It is after the report that was received and finding that the subject drug was not of standard quality, proceedings were instituted against the petitioners and several other accused for offences punishable under Section 27(a) of the Act for alleged violation of Section 18(a)(i) of the Act. The petitioners 1 and 2 are Proprietors/Directors of the 3rd petitioner M/s.Unicorn Meditech, the manufacturer of the subject drug and other drugs.
5. Alleging violation of Section 18(a)(i) of the Act which becomes punishable under Section 27(a) of the Act, a complaint is registered by the respondents invoking Section 200 of the Cr.P.C. The complaint, though is at great length, does not indicate the role of the petitioners to be in the day-to-day affairs of manufacturing of drugs in the company. Unless this is spelt out, the offences against the petitioners cannot be driven home, is the consistent view taken by this Court in plethora of judgments right from the year 2000.
6. A Co-ordinate Bench of this Court in the case of SANJAY G. REVANKAR v. STATE BY DRUG INSPECTOR, U.K.DISTRICT, KARWAR, ILR 2002 KAR 475 has held as follows:
“More often it is common that some of the partners of the firm may not even be knowing of what is going on day-to-day in the firm. There may be partners, better known as sleeping partners
The main legal point established in the judgment is that specific and clear averments regarding the role and responsibilities of the accused in the commission of the offence are necessary to establis....
Vicarious liability under the Drugs and Cosmetics Act, 1940 arises if the person was in charge and responsible for the day-to-day affairs of the company at the time of the offence, and the company mu....
Directors of a company not involved in drug manufacturing cannot be held liable under the Drugs and Cosmetics Act absent specific evidence of their responsibility for the conduct of business.
The main legal point established in the judgment is that for making a director of a company liable for offences committed by the company under the Drugs & Cosmetics Act, 1940, there must be specific ....
Under Section 34 Drugs and Cosmetics Act, company offence liability presumes against nominated responsible person and firm; other officers require specific role allegations, not mere designations.
Vicarious liability under the Drugs and Cosmetics Act requires specific averments in the complaint to establish that individuals were in charge of and responsible for the conduct of the business at t....
Directors cannot be held liable for a company's criminal acts without specific allegations of their involvement; mere directorship is insufficient for establishing vicarious liability.
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.